ARCHIVES

Degarelix Active In Phase II Trial In Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 10 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named.

March 24, 2006

Obituary: Ernst Wynder, 77, Linked Smoking, Cancer

July 23, 1999

Pathology In Operating Suite Cuts Need for More Surgery

February 24, 2012

R.S.K. Young Quits As FDA Oncology Group Leader

July 11, 1980

NCI Still Trying To Broaden Group B Drug Distribution

May 5, 1978

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008